Novogen (NVGN)

Add to Watchlists
Create an Alert
3.93 -0.11  -2.72% NASDAQ Apr 23, 8:00PM BATS Real time Currency in USD
View Full Chart
NVGN Price Chart
View All Events

NVGN Events

Date Type Description
Nov 15 Misc AGM Event for Novogen Limited
View All Performance Charts

NVGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Novogen is down 18.12% over the last year vs S&P 500 Total Return up 21.54%, AstraZeneca up 39.09%, and ntercept Pharmaceuticals up 674.2%.

Get Quote for
Advertisement

Portfolio Strategies Featuring NVGN

Did Novogen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NVGN Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Headquarters Country: Australia
  • Headquarters State/Province: N/A
  • Incorporation Country: Australia
  • Incorporation State/Province: N/A
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: June 30, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A

Novogen Ltd., is engaged in pharmaceutical drug development. It develops single drug capable of killing both the dominant differentiated cells in a cancer as well as the undifferentiated cancer stem cells at a therapeutic dose.

Recent Quotes

Symbol Price Chg Chg % Market Cap
NVGN 3.93 -0.11 -2.72% 25.39M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.